| ARVN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ARVN market cap history going back to 9/27/2018:
Also see: ARVN Shares Outstanding History and ARVN YTD Return |
As of 5/7/2026 Arvinas has a market cap of 657.47 million. Investors often follow the ARVN market cap history to compare the size of the company over time.
This page shows ARVN market capitalization trends over time, with 32 market cap datapoints presented, dating back to 9/27/2018.

| ARVN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ARVN market cap history going back to 9/27/2018:
Also see: ARVN Shares Outstanding History and ARVN YTD Return |
| ARVN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARVN Historical Market Cap: +3.65% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ARVN Stock Price Chart |
| About Arvinas Inc |
| Arvinas, Inc. is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Co. uses its PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. We show 32 historical shares outstanding datapoints in our ARVN shares outstanding history coverage, used to compute ARVN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARVN market cap history over the course of time is important for investors interested in comparing ARVN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARVN versus a peer is one thing; comparing ARVN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARVN can fluctuate over the course of history. With this page we aim to empower investors researching ARVN by allowing them to research the ARVN market cap history. |
| ARVN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| ARVN Share Performance |
| Market Cap Peers |
| Arvinas (ARVN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ARWR Market Cap History ASMB Market Cap History ASPI Market Cap History ASRT Market Cap History ASTH Market Cap History ATAI Market Cap History ATEC Market Cap History ATHA Market Cap History ATHX Market Cap History ATIP Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.